Shoulder Innovations (NYSE:SI) CFO Jeffrey Points Buys 1,005 Shares

Shoulder Innovations, Inc. (NYSE:SI) CFO Jeffrey Points bought 1,005 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were purchased at an average price of $14.98 per share, with a total value of $15,054.90. Following the transaction, the chief financial officer directly owned 54,445 shares in the company, valued at $815,586.10. This represents a 1.88% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shoulder Innovations Trading Up 0.8%

NYSE:SI opened at $14.49 on Tuesday. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $17.94. The company has a 50-day moving average price of $13.45.

Shoulder Innovations (NYSE:SI) last released its quarterly earnings results on Tuesday, November 11th. The company reported ($0.48) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.11). The company had revenue of $11.76 million during the quarter, compared to analysts’ expectations of $9.99 million. Research analysts predict that Shoulder Innovations, Inc. will post -0.56 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have commented on SI. Morgan Stanley increased their price objective on shares of Shoulder Innovations from $18.00 to $23.00 and gave the stock an “overweight” rating in a report on Tuesday, December 2nd. Jefferies Financial Group assumed coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They set a “buy” rating and a $19.00 target price on the stock. Zacks Research raised shares of Shoulder Innovations to a “hold” rating in a report on Tuesday, August 26th. Wall Street Zen upgraded shares of Shoulder Innovations from a “sell” rating to a “hold” rating in a research report on Saturday, October 11th. Finally, Weiss Ratings reiterated a “sell (e)” rating on shares of Shoulder Innovations in a research report on Monday, December 8th. Five investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.60.

Institutional Investors Weigh In On Shoulder Innovations

A number of institutional investors and hedge funds have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Shoulder Innovations in the third quarter valued at approximately $28,000. Rhumbline Advisers bought a new stake in shares of Shoulder Innovations during the 3rd quarter valued at $54,000. Board of Trustees of The Leland Stanford Junior University acquired a new position in shares of Shoulder Innovations in the 3rd quarter valued at $170,000. Bank of America Corp DE bought a new position in shares of Shoulder Innovations in the 3rd quarter worth $322,000. Finally, Monashee Investment Management LLC acquired a new stake in shares of Shoulder Innovations during the third quarter worth $502,000.

About Shoulder Innovations

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.